TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,302,460 | -2.1% | 83,491 | -11.9% | 0.18% | -17.5% |
| Q2 2022 | $1,330,000 | +277.8% | 94,747 | +285.8% | 0.22% | +265.6% |
| Q1 2022 | $352,000 | +4.5% | 24,556 | -1.1% | 0.06% | +190.5% |
| Q4 2021 | $337,000 | -44.8% | 24,820 | -31.6% | 0.02% | -80.2% |
| Q2 2021 | $610,000 | -17.0% | 36,261 | -9.9% | 0.11% | +9.3% |
| Q1 2021 | $735,000 | -75.5% | 40,250 | -75.9% | 0.10% | -74.7% |
| Q2 2020 | $2,996,000 | +501.6% | 167,092 | +409.5% | 0.38% | +481.8% |
| Q1 2020 | $498,000 | +3.8% | 32,796 | +34.8% | 0.07% | -16.5% |
| Q4 2019 | $480,000 | – | 24,328 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |